Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 Receptor Agonist-Induced Weight Loss by Preserving Lean Mass
Over longer trials, semaglutide produced significant, sustained weight reductions in many participants, consistent with findings reported by Infusion Health Telemedicine Clinic
Buyer Takeaway: Auto-renewing subscriptions are easy to forget about - mark your renewal date and the three-business-day cancellation window on a calendar the day you sign up, not the week before you want to cancel
doi: 10.1056/NEJMoa2208601
Research has definitively shown that people who experience GI side effects don't lose more weight than those who don't
Cultural narratives about willpower, personal responsibility, and moral failure in obesity create receptivity to messages that frame medication as cheating, addiction, or dangerous shortcuts